NASDAQ: WAYWaystar Holding Corp Stock
$36.45-0.26 (-0.71%)
Updated Apr 17, 2025
WAY Price
$36.45
Fair Value Price
$14.36
Market Cap
$6.27B
52 Week Low
$20.26
52 Week High
$48.11
P/E
-280.38x
P/B
2.04x
P/S
5.83x
PEG
N/A
Dividend Yield
N/A
Revenue
$943.55M
Earnings
-$19.13M
Gross Margin
66.5%
Operating Margin
13.11%
Profit Margin
-2%
Debt to Equity
0.49
Operating Cash Flow
$170M
Beta
0.85
Next Earnings
May 1, 2025
Ex-Dividend
N/A
Next Dividend
N/A
WAY Overview
Waystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payment management, denial prevention and recovery, revenue capture, and analytics and reporting solutions. The company primarily serves healthcare industry. Waystar Holding Corp. was founded in 2017 and is based in Lehi, Utah.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine WAY's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
B
WAY
Ranked#8 of 44
Ranked#8 of 44
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $149.00 | A | |
| $62.37 | A | |
| $1.42 | B |
Be the first to know about important WAY news, forecast changes, insider trades & much more!
WAY News
Overview
Due Diligence Score
–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how WAY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
WAY ($36.45) is overvalued by 153.88% relative to our estimate of its Fair Value price of $14.36 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
WAY ($36.45) is not significantly undervalued (153.88%) relative to our estimate of its Fair Value price of $14.36 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
WAY is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more WAY due diligence checks available for Premium users.
Valuation
WAY fair value
Fair Value of WAY stock based on Discounted Cash Flow (DCF)
Price
$36.45
Fair Value
$14.36
Overvalued by
153.88%
WAY ($36.45) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
WAY ($36.45) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
WAY is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
WAY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-280.38x
Industry
11.14x
Market
27.98x
WAY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.04x
Industry
3.39x
WAY is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
WAY's financial health
Profit margin
Revenue
$244.1M
Net Income
$19.1M
Profit Margin
7.8%
WAY's Earnings (EBIT) of $123.73M... subscribe to Premium to read more.
Interest Coverage Financials
WAY's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.6B
Liabilities
$1.5B
Debt to equity
0.49
WAY's short-term assets ($371.04M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
WAY's long-term liabilities ($1.35B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
WAY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$64.8M
Investing
-$6.2M
Financing
$1.7M
WAY's operating cash flow ($169.77M)... subscribe to Premium to read more.
Debt Coverage Financials
WAY vs Health Information Service Stocks
Waystar Holding Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.